Immediate Impact
3 from Science/Nature 81 standout
Citing Papers
Lorlatinib Versus Crizotinib in Patients With Advanced ALK -Positive Non–Small Cell Lung Cancer: 5-Year Outcomes From the Phase III CROWN Study
2024 Standout
Lymph-node-targeted, mKRAS-specific amphiphile vaccine in pancreatic and colorectal cancer: the phase 1 AMPLIFY-201 trial
2024 Standout
Works of Michael Zaidinski being referenced
Prevalence, Clinicopathologic Associations, and Molecular Spectrum of ERBB2 ( HER2 ) Tyrosine Kinase Mutations in Lung Adenocarcinomas
2012
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Michael Zaidinski | 333 | 297 | 88 | 127 | 4 | 401 | |
| G. Groth | 274 | 258 | 71 | 100 | 7 | 367 | |
| She-Juan An | 361 | 278 | 31 | 137 | 7 | 447 | |
| M Paesmans | 192 | 221 | 48 | 155 | 6 | 445 | |
| Ghislaine Sierankowski | 168 | 214 | 44 | 123 | 7 | 375 | |
| Amy Tilley | 200 | 302 | 106 | 105 | 5 | 430 | |
| Petra Heinmöller | 135 | 271 | 92 | 131 | 6 | 360 | |
| Kazuto Furuyama | 164 | 165 | 38 | 176 | 5 | 360 | |
| Pei Ni Ding | 306 | 227 | 16 | 116 | 6 | 392 | |
| Andrea E. Doak | 250 | 199 | 29 | 159 | 7 | 345 | |
| Silvia Chiorrini | 112 | 214 | 28 | 115 | 6 | 368 |
All Works
Login with ORCID to disown or claim papers
Loading papers...